期刊文献+

胆管癌中EGFR、nm23 H1基因表达及其意义 被引量:2

Expression and significance of EGFR,gene nm23H1 in cholangiocarcinoma
下载PDF
导出
摘要 目的 :探讨表皮生长因子受体 (EGFR)和肿瘤转移抑制基因nm2 3H1在胆管癌的表达及其意义。方法 :采用免疫组化SABC法检测 2 1例胆管癌及 15例胆管炎组织中EGFR、nm2 3H1基因蛋白产物 ,并分析其意义。结果 :胆管癌中nm2 3H1阳性表达率低于胆管炎组织 (P <0 .0 5 ) ,而EGFR在胆管癌组织中的阳性表达率则显著升高 (P <0 .0 1) ,nm2 3H1的表达与胆管癌TNM分期呈负相关 (P <0 .0 1)。结论 :EGFR的高表达和nm2 3H1的低表达参与胆管癌的发生、发展。 Objective:To evaluate the expression of EGFR and gene nm23H1 and their relation to the tumor oncogenesis and progress of cholangiocarcinoma.Methods:SABC immunohistochemistry was used to detect the expression of EGFR and nm23H1 in cholangiocarcinoma and cholangitis tissue.Results:The positive rate of nm23H1 in cholangiocarcinoma was lower than cholangitis(P<0.05),while that of EGFR increased significantly(P<0.05).The expression of nm23H1 was negtive related to tumor TNM stage (P<0.05).Conclusion:It is suggested that over expression of EGFR and lower expression of nm23H1 is involved in the oncogenesis and progress of cholangiocarcinoma
出处 《中国现代普通外科进展》 CAS 2002年第3期172-173,共2页 Chinese Journal of Current Advances in General Surgery
关键词 胆管癌 受体 表皮生长因子 尿抑胃素 NM23H1 基因表达 临床意义 Bile duct neoplasms Receptors,epidermal growth factor urogastrone Gene,nm23H1 Gene expression
  • 相关文献

参考文献3

二级参考文献3

共引文献35

同被引文献38

  • 1王炳生,钱振宇,刘厚宝,秦净,童赛雄.胆管癌病因的初步探讨[J].中华普通外科杂志,2004,19(10):642-643. 被引量:1
  • 2刘子沛,朱瑾,周金莲,熊燕,王曙光.胆管癌组织中真核细胞翻译起始因子4E和基质金属蛋白酶-9的表达及临床意义的研究[J].消化外科,2005,4(2):113-118. 被引量:8
  • 3张炳远,张建余,赵凯,吴力群.胆管癌组织Smad4和转化生长因子β_1及Ⅱ型受体的表达及意义[J].中华外科杂志,2005,43(13):846-849. 被引量:14
  • 4Biberg KM, Schrumpf E, Bergquist A,et al. Cholangiocarcinoma in primary sclerosing cholangitis:K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development[J]. J Hepatol. 2000 32(3) :374-80.
  • 5Isa T, Tomita S, Nakachi A,et al. Analysis of microsatellite instability, K ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma[J]. Hepatogastroenterology. 200249(45) :604-8.
  • 6Ukita Y, Kato M, Terada T. Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry[J]. J Hepatol. 2002 36(6) :780-5.
  • 7Aishima SI, Taguchi KI,Sugimachi K et al. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma[J]. Histopathology. 2002 40(3):269-78.
  • 8Ito Y, Tadeda Y, Sakon M,et al. Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma: its relationship with biological features[J]. Anticancer Res. 2000 20(5C): 3891-5.
  • 9Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcionoma in the United States[J]. Hepatology,2001 33(6):1353-7.
  • 10Taylar-robinson SD, Toledano MB, Arora s, et al. Increase in mortality rates from introhepatic cholangiocarcinoma in England and Wales 1968-1998[J]. Gut, 2001 ; 48: 816-820.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部